id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-P-0172-0039,FDA,FDA-2023-P-0172,Exhibit K_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-07T00:02:02Z,,0,0,09000064b919073e
FDA-2023-P-0172-0028,FDA,FDA-2023-P-0172,Exhibit J,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:55:17Z,,0,0,09000064b91904a3
FDA-2023-P-0172-0023,FDA,FDA-2023-P-0172,Exhibit E,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:53:08Z,,0,0,09000064b9190474
FDA-2023-P-0172-0033,FDA,FDA-2023-P-0172,Exhibit C_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:59:17Z,,0,0,09000064b919070d
FDA-2023-P-0172-0030,FDA,FDA-2023-P-0172,Exhibit L,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:57:46Z,,0,0,09000064b9196ddd
FDA-2023-P-0172-0019,FDA,FDA-2023-P-0172,Exhibit A,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:51:18Z,,0,0,09000064b919042d
FDA-2023-P-0172-0024,FDA,FDA-2023-P-0172,Exhibit F,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:53:53Z,,0,0,09000064b919047a
FDA-2023-P-0172-0025,FDA,FDA-2023-P-0172,Exhibit G,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:54:19Z,,0,0,09000064b919049d
FDA-2023-P-0172-0020,FDA,FDA-2023-P-0172,Exhibit B,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:51:39Z,,0,0,09000064b919042f
FDA-2023-P-0172-0021,FDA,FDA-2023-P-0172,Exhibit C,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:52:09Z,,0,0,09000064b9190431
FDA-2023-P-0172-0027,FDA,FDA-2023-P-0172,Exhibit I,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:54:56Z,,0,0,09000064b919049f
FDA-2023-P-0172-0032,FDA,FDA-2023-P-0172,Exhibit B_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:59:00Z,,0,0,09000064b919070c
FDA-2023-P-0172-0029,FDA,FDA-2023-P-0172,Exhibit K,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:55:39Z,,0,0,09000064b91904bc
FDA-2023-P-0172-0037,FDA,FDA-2023-P-0172,Exhibit G_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-07T00:01:17Z,,0,0,09000064b919072a
FDA-2023-P-0172-0035,FDA,FDA-2023-P-0172,Exhibit E_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-07T00:00:19Z,,0,0,09000064b9190723
FDA-2023-P-0172-0036,FDA,FDA-2023-P-0172,Exhibit F_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-07T00:00:57Z,,0,0,09000064b9190729
FDA-2023-P-0172-0034,FDA,FDA-2023-P-0172,Exhibit D_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-07T00:00:01Z,,0,0,09000064b919070f
FDA-2023-P-0172-0026,FDA,FDA-2023-P-0172,Exhibit H,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:54:42Z,,0,0,09000064b919049e
FDA-2023-P-0172-0022,FDA,FDA-2023-P-0172,Exhibit D,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:52:39Z,,0,0,09000064b9190473
FDA-2023-P-0172-0018,FDA,FDA-2023-P-0172,"Petition for Reconsideration from Keller & Heckman LLP  on behalf of Lucy Goods, Inc",Other,Petition for Reconsideration,2026-02-06T05:00:00Z,2026,2,2026-02-06T05:00:00Z,,2026-02-06T23:49:41Z,,0,0,09000064b91903d0
FDA-2023-P-0172-0040,FDA,FDA-2023-P-0172,Exhibit L -Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-07T00:03:11Z,,0,0,09000064b9196dde
FDA-2023-P-0172-0038,FDA,FDA-2023-P-0172,Exhibit H_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-07T00:01:43Z,,0,0,09000064b919072c
FDA-2023-P-0172-0031,FDA,FDA-2023-P-0172,Exhibit A_Redacted,Supporting & Related Material,Background Material,2026-02-06T05:00:00Z,2026,2,,,2026-02-06T23:58:37Z,,0,0,09000064b919070b
FDA-2023-P-0172-0017,FDA,FDA-2023-P-0172,Response Letter from FDA CTP to Keller and Heckman LLP,Other,Letter(s),2026-01-09T05:00:00Z,2026,1,2026-01-09T05:00:00Z,,2026-01-10T00:49:29Z,,0,0,09000064b912189b
FDA-2023-P-0172-0016,FDA,FDA-2023-P-0172,Interim Response from FDA CTP to Keller and Heckman LLP,Other,Response(s),2023-07-13T04:00:00Z,2023,7,2023-07-13T04:00:00Z,,2023-07-13T20:17:01Z,,0,0,0900006485ca4636
FDA-2023-P-0172-0015,FDA,FDA-2023-P-0172,Exhibit B Re: Supplement to Petition for Stay of Action from Keller and Heckman LLP on behalf of Lucy Goods Inc,Supporting & Related Material,Exhibits,2023-05-08T04:00:00Z,2023,5,,,2023-05-08T18:04:15Z,,0,0,09000064859dfd0d
FDA-2023-P-0172-0010,FDA,FDA-2023-P-0172,Supplement To Citizen Petition from Keller and Heckman LLP on behalf of Lucy Goods Inc,Other,Supplement (SUP),2023-05-08T04:00:00Z,2023,5,2023-05-08T04:00:00Z,,2023-05-08T18:02:37Z,,0,0,09000064859df0b5
FDA-2023-P-0172-0014,FDA,FDA-2023-P-0172,Exhibit A Re: Supplement to Petition for Stay of Action from Keller and Heckman LLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-05-08T04:00:00Z,2023,5,,,2023-05-08T18:03:49Z,,0,0,09000064859dfd0c
FDA-2023-P-0172-0012,FDA,FDA-2023-P-0172,Exhibit A Re: Supplement to Citizen Petition from Keller and Heckman LLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-05-08T04:00:00Z,2023,5,,,2023-05-08T18:03:11Z,,0,0,09000064859df804
FDA-2023-P-0172-0013,FDA,FDA-2023-P-0172,Exhibit B Re: Supplement to Citizen Petition from Keller and Heckman LLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-05-08T04:00:00Z,2023,5,,,2023-05-08T18:03:34Z,,0,0,09000064859df805
FDA-2023-P-0172-0011,FDA,FDA-2023-P-0172,Supplement To Petition for Stay of Action from Keller and Heckman LLP on behalf of Lucy Goods Inc,Other,Supplement (SUP),2023-05-08T04:00:00Z,2023,5,2023-05-08T04:00:00Z,,2023-05-08T18:02:55Z,,0,0,09000064859df0b7
FDA-2023-P-0172-0003,FDA,FDA-2023-P-0172,Acknowledgement Letter from FDA DMS to Keller and Heckman LLP on behalf of Lucy Goods Inc.,Other,Acknowledgement Letter/Receipt,2023-01-18T05:00:00Z,2023,1,2023-01-18T05:00:00Z,,2023-01-18T21:40:20Z,,0,0,09000064855f1d02
FDA-2023-P-0172-0001,FDA,FDA-2023-P-0172,"Citizen Petition from Keller and Heckman LLP on behalf of Lucy Goods, Inc",Other,Citizen Petition,2023-01-18T05:00:00Z,2023,1,2023-01-18T05:00:00Z,,2023-05-04T14:59:48Z,,0,0,09000064855f18a1
FDA-2023-P-0172-0002,FDA,FDA-2023-P-0172,Petition for Stay of Action from Keller and Heckman LLP on behalf of Lucy Goods Inc,Other,Petition(s),2023-01-18T05:00:00Z,2023,1,2023-01-18T05:00:00Z,,2023-01-18T21:40:14Z,,0,0,09000064855f5987
FDA-2023-P-0172-0005,FDA,FDA-2023-P-0172,Exhibit A re Citizen Petition from Keller and Heckman CLLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-01-13T05:00:00Z,2023,1,,,2023-05-08T16:21:08Z,,0,0,09000064855f1d01
FDA-2023-P-0172-0004,FDA,FDA-2023-P-0172,Attachment 1 re Citizen Petition from Keller and Heckman LLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-01-13T05:00:00Z,2023,1,,,2026-02-04T23:16:57Z,,0,0,09000064855f19d6
FDA-2023-P-0172-0006,FDA,FDA-2023-P-0172,Exhibit B re Citizen Petition from Keller and Heckman CLLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-01-13T05:00:00Z,2023,1,,,2023-05-08T16:21:33Z,,0,0,09000064855f19d9
FDA-2023-P-0172-0007,FDA,FDA-2023-P-0172,Attachment 1 re: Petition for Stay of Action  Keller and Heckman LLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-01-13T05:00:00Z,2023,1,,,2023-05-08T16:25:28Z,,0,0,09000064855f5b35
FDA-2023-P-0172-0008,FDA,FDA-2023-P-0172,Exhibit A re: Petition for Stay of Action from Keller and Heckman LLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-01-13T05:00:00Z,2023,1,,,2023-05-08T17:25:36Z,,0,0,09000064855f5b36
FDA-2023-P-0172-0009,FDA,FDA-2023-P-0172,Exhibit B re: Petition for Stay of Action from  Keller and Heckman LLP on behalf of Lucy Goods Inc,Supporting & Related Material,Background Material,2023-01-13T05:00:00Z,2023,1,,,2023-05-08T17:25:48Z,,0,0,09000064855f5b71